Financhill
Sell
15

BOIRF Quote, Financials, Valuation and Earnings

Last price:
$30.00
Seasonality move :
-2.53%
Day range:
$30.00 - $30.00
52-week range:
$24.00 - $32.28
Dividend yield:
4.55%
P/E ratio:
24.71x
P/S ratio:
0.95x
P/B ratio:
1.09x
Volume:
--
Avg. volume:
17
1-year change:
5.26%
Market cap:
$520.9M
Revenue:
$527.4M
EPS (TTM):
$1.21

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Boiron SA has -- downside to fair value with a price target of -- per share.

BOIRF vs. S&P 500

  • Over the past 5 trading days, Boiron SA has underperformed the S&P 500 by -0.1% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Boiron SA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Boiron SA has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Boiron SA reported revenues of --.

Earnings Growth

  • Boiron SA has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Boiron SA reported earnings per share of --.
Enterprise value:
404.8M
EV / Invested capital:
--
Price / LTM sales:
0.95x
EV / EBIT:
7.97x
EV / Revenue:
0.74x
PEG ratio (5yr expected):
0.76x
EV / Free cash flow:
9.27x
Price / Operating cash flow:
11.92x
Enterprise value / EBITDA:
4.80x
Gross Profit (TTM):
$404.6M
Return On Assets:
3.7%
Net Income Margin (TTM):
3.84%
Return On Equity:
5.35%
Return On Invested Capital:
5.31%
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2010-12-31 2011-12-31 2012-12-31 2011-12-31 2012-12-31
Income Statement
Revenue $688.6M $726.9M $726.5M -- $216.5M
Gross Profit $541.4M $562.1M $565M -- --
Operating Income $83.1M $85.8M $108.4M -- --
EBITDA $110.2M $112.2M $143.1M -- --
Diluted EPS $2.67 $2.72 $3.02 -- --
Period Ending 2021-06-30 2022-06-30 2023-06-30 2024-06-30 2025-06-30
Balance Sheet
Current Assets $477.8M $467.7M $482M $274M --
Total Assets $873.8M $805M $818.1M $597.7M --
Current Liabilities $185.5M $161.1M $145.3M $122.1M --
Total Liabilities $291.3M $248.5M $220.3M $198M --
Total Equity $582.5M $556.5M $597.7M $399.8M --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-21 2024-12-21 2024-12-21
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
BOIRF
Sector
Market Cap
$520.9M
$27.9M
Price % of 52-Week High
92.94%
51.04%
Dividend Yield
4.55%
0%
Shareholder Yield
4.82%
-1.49%
1-Year Price Total Return
5.26%
-16.66%
Beta (5-Year)
0.200
0.516
Dividend yield:
4.55%
Annualized payout:
$1.47
Payout ratio:
858.19%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $30.00
200-day SMA
Buy
Level $27.65
Bollinger Bands (100)
Buy
Level 23.79 - 29.81
Chaikin Money Flow
Sell
Level -35
20-day SMA
Sell
Level $30.00
Relative Strength Index (RSI14)
Buy
Level 62.85
ADX Line
Buy
Level 33.06
Williams %R
Buy
Level -100
50-day SMA
Buy
Level $28.88
MACD (12, 26)
Buy
Level 0.20
25-day Aroon Oscillator
Sell
Level 0
On Balance Volume
Sell
Level -14.8K

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.4587)
Buy
CA Score (Annual)
Level (0.887)
Buy
Beneish M-Score (Annual)
Level (-2.771)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.0072)
Buy
Piotroski F Score (Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Boiron SA engages in the manufacturing and selling homeopathic medicines. It operates through the following geographical segments: France; Europe; North America; and Other Countries. The company offers non-proprietary, proprietary and branded homeopathic medicines. Boiron was founded by Jean Boiron and Henri Boiron on June 7, 1932 and is headquartered in Messimy, France.

Stock Forecast FAQ

In the current month, BOIRF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The BOIRF average analyst price target in the past 3 months is --.

  • Where Will Boiron SA Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Boiron SA share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Boiron SA?

    Analysts are divided on their view about Boiron SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Boiron SA is a Sell and believe this share price will rise from its current level to --.

  • What Is Boiron SA's Price Target?

    The price target for Boiron SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is BOIRF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Boiron SA is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of BOIRF?

    You can purchase shares of Boiron SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Boiron SA shares.

  • What Is The Boiron SA Share Price Today?

    Boiron SA was last trading at $30.00 per share. This represents the most recent stock quote for Boiron SA. Yesterday, Boiron SA closed at $30.00 per share.

  • How To Buy Boiron SA Stock Online?

    In order to purchase Boiron SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Is Berkshire Hathaway Stock Undervalued?
Is Berkshire Hathaway Stock Undervalued?

Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…

Is Oracle Stock Undervalued?
Is Oracle Stock Undervalued?

Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
57
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 38x

Alerts

Sell
1
LW alert for Dec 20

Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.

Buy
54
BMRN alert for Dec 20

BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.

Buy
82
RKLB alert for Dec 20

Rocket Lab Corp. [RKLB] is up 17.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock